Episode 73: Isaac Stoner, CEO, MindImmune Therapeutics, Inc.

from Few & Far Between: How Biotech Gets Built · host Chris O'Brien

Today on the Biorasi Few & Far Between podcast: Host Melissa Alesse welcomes Isaac Stoner, CEO of MindImmune Therapeutics, back to the podcast for a conversation on the evolving science of Alzheimer's disease and the challenges of biotech leadership. We'll explore Alzheimer's through the lens of the immune system, discuss drug development from the perspective of investors and operators, and dive into the power of networking in Boston's biotech ecosystem. And be sure to stick around for our lightning round - quick answers to important questions. Watch this episode today!

Episode metadata supplied by the publisher feed · Published Aug 11, 2026

Embed this episode

Attribution link and audio player

Ready to play

Episode 73: Isaac Stoner, CEO, MindImmune Therapeutics, Inc.

0:00 37:04

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Few & Far Between: How Biotech Gets Built?

This episode is 37 minutes long.

When was this Few & Far Between: How Biotech Gets Built episode published?

This episode was published on August 11, 2026.

Can I download this Few & Far Between: How Biotech Gets Built episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!